Sun, Feb 1, 2015, 7:04 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

  • uplatas uplatas Nov 7, 2013 4:28 PM Flag


    A message from
    Carolyn Logan, CEO of Salix Pharmaceuticals
    At Salix, we work hard every day to meet the current and anticipated needs of patients and healthcare providers. We are excited about the opportunity to drive this mission forward and announced today our intention to purchase Santarus, Inc., a specialty biopharmaceutical company focused on providing gastroenterology products and other select specialties. Both Salix and Santarus share a commitment to integrity, ethics, teamwork, accountability and innovation. Through this acquisition, we will expand our ability to reach more patients and provide the additional products they need. We are excited to create a new company with greater scope and impact than either company could offer independently. This expansion is transformational for Salix, and I want to thank our employees and the employees at Santarus for their commitment and hard work that helped make this possible.

31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.